Possible Treatment for Hypothalamic Obesity and Prader-Willi Syndrome Will be Tested in Phase 2 Trial
mohamed_hassan / Pixabay

Possible Treatment for Hypothalamic Obesity and Prader-Willi Syndrome Will be Tested in Phase 2 Trial

According to a story from GlobeNewswire, the biotech company Saniona has recently announced plans to begin the design and initiation of a Phase 2a clinical trial study of its investigational…

Continue Reading Possible Treatment for Hypothalamic Obesity and Prader-Willi Syndrome Will be Tested in Phase 2 Trial
Close Menu